Staphylococcus aureus in Community-Acquired Pneumonia

To the Editor:
We are concerned about the frequencies of bacterial pathogens in patients with culture-positive community-acquired pneumonia (CAP) that were reported by Kollef et al (December 2005 ). 1 Among 2,221 such patients, Staphylococcus aureus was identified in 25.5% of patients, Streptococcus pneumoniae was identified in 16.6% of patients, and Haemophilus influenzae was identified in 16.6% of patients.
From November 1999 to October 2003, 668 patients who were hospitalized in our department had a discharge code of pneumonia, chest radiograph infiltrates, and no hospitalization during the preceding month. Among 191 patients (median age, 68 years) with culture-positive CAP (ie, significant bacterial pathogens identified by blood culture [n ϭ 60] and/or sputum culture), S pneumoniae was identified in 57% (n ϭ 109; 46 bacteremic cases), H influenzae was identified in 27% (n ϭ 51; 3 bacteremic cases), and S aureus was identified in 7.3% (n ϭ 14; 5 bacteremic cases). This frequency of S aureus is consistent with the level of 2.9% in seven previous studies of hospitalized CAP patients that were summarized by Marrie. 2 In our opinion, the frequencies of bacterial pathogens reported by Kollef et al 1 are too odd to support the guideline recommendations for CAP.
In the pneumonia population in the study by Kollef et al, 1 S aureus was the only pathogen that was associated with increased mortality. Among our CAP patients detailed above, death within 30 days occurred in 29% of the 14 patients with S aureus identified (n ϭ 4; one bacteremic case), compared with 5.1% of the 177 other patients with culture-positive CAP (n ϭ 9; nine bacteremic cases; p ϭ 0.009 [Fisher exact test]). Severe necrotizing pneumonia can be caused by S aureus carrying the Panton-Valentine leukocidin gene. 3 However, S aureus isolates from three of our patients who died were tested and were negative for the Panton-Valentine leukocidin gene. 4 Since S aureus is an uncommon cause of CAP, it does not need to be covered by the empirical CAP treatment. However, the severity associated with S aureus pneumonia reinforces the importance of performing routine blood and respiratory cultures in pneumonia patients. 
